China Chondroitin Sulfate Market Size & Outlook, 2022-2030
China chondroitin sulfate market, 2017-2030 (US$M)
Related Markets
China chondroitin sulfate market highlights
- The China chondroitin sulfate market generated a revenue of USD 71.2 million in 2022 and is expected to reach USD 97.5 million by 2030.
- The China market is expected to grow at a CAGR of 4% from 2023 to 2030.
- In terms of segment, bovine was the largest revenue generating source in 2022.
- Synthetic is the most lucrative source segment registering the fastest growth during the forecast period.
Chondroitin sulfate market data book summary
| Market revenue in 2022 | USD 71.2 million |
| Market revenue in 2030 | USD 97.5 million |
| Growth rate | 4% (CAGR from 2022 to 2030) |
| Largest segment | Bovine |
| Fastest growing segment | Synthetic |
| Historical data | 2017 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bovine, Swine, Poultry, Shark, Synthetic |
| Key market players worldwide | Merck KGaA, BRF SA ADR, Seikagaku, TSI Group, Bioiberica, Bio-gen Extracts |
Other key industry trends
- In terms of revenue, China accounted for 5.8% of the global chondroitin sulfate market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China chondroitin sulfate market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 91.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Chondroitin Sulfate Market Scope
Chondroitin Sulfate Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China chondroitin sulfate market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chondroitin sulfate market will help companies and investors design strategic landscapes.
Bovine was the largest segment with a revenue share of 38.62% in 2022. Horizon Databook has segmented the China chondroitin sulfate market based on bovine, swine, poultry, shark, synthetic covering the revenue growth of each sub-segment from 2017 to 2030.
China accounts for a majority of the global chondroitin sulfate production. China majorly exports nutraceutical and pharmaceutical grade chondroitin sulfate to the U.S. and the European countries.
Easy access to raw materials is anticipated to be a key factor triggering the growth of chondroitin sulfate market in the country. Chondroitin sulfate sourced from porcine is used in a combination with MSM and glucosamine in dietary supplements for joint health.
It is also used in pharmaceutical industry to produce injections for treating osteoarthritis as well as for skin nourishment and repairing in cosmetics industry. Bovine sourced chondroitin sulfate is mostly used in food and pharmaceutical sectors.
Reasons to subscribe to China chondroitin sulfate market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China chondroitin sulfate market databook
-
Our clientele includes a mix of chondroitin sulfate market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China chondroitin sulfate market , including forecasts for subscribers. This country databook contains high-level insights into China chondroitin sulfate market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China chondroitin sulfate market size, by source, 2017-2030 (US$M)
China Chondroitin Sulfate Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
